Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The trial reported a 26% reduction in the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
Patients provided written informed consent prior to collection
Proud to contribute to this important conversation
GLP-1 receptor agonists, such as semaglutidemarketed as Ozempic for diabetes and Wegovy for weight managementmimic the action of the glucagon-like peptide-1 hormone
All while navigating the inevitable political backlash over the cost of these drugs (not something to ignore after they passed the Inflation Reduction Act and are even talking about march-in-rights on patents!)
US$ 29.73
US$ 27.71
US$ 25.61
US$ 20.83
US$ 29.46
US$ 29.49
US$ 21.66
